EnginZyme
SwedenEntry
2022
Hold
4yr
Status
Active
Who owns EnginZyme?
EnginZyme is a Swedish Biotech company, currently owned by Almi Invest since 2022 and 3 other investors.
Hand-verified · updated 2026-09-30
Open JSON · CC-BY
Most recent investor
Navigare VenturesNavigare Ventures · 2021 · VC
4 ownership periods · full history below
Key facts
HQSweden
SectorBiotech
Key takeaways
- ·Co-held by Sofinnova Partners, Industrifonden, Almi Invest and Navigare Ventures since 2019.
- ·4 distinct PE sponsors across ownership cycles.
Ownership history
4 ownership periods · co-invest detected
Active
Co-invest · 4 holders · 2019 · present
Sofinnova PartnersActive
2019 · present(7yr) · Sofinnova Industrial Biotech · 2018 · VC
IndustrifondenActive
2021 · present(5yr) · Industrifonden Evergreen · 1991 · VC
Navigare VenturesActive
2022 · present(4yr) · Navigare Ventures · 2021 · VC
Almi InvestActive
2022 · present(4yr) · Almi Invest (Regional funds) · 2009 · VC
More from Navigare Ventures
Other portfolio companies in the same fund.
More PE-backed in Biotech
Comparable biotech deals from other GPs.
USQuestions
Who owns EnginZyme?
EnginZyme is currently owned by Almi Invest, Navigare Ventures and 2 others, through Navigare Ventures, since 2022.
When did Almi Invest and 3 others acquire EnginZyme?
Almi Invest and 3 others acquired EnginZyme in 2022.
Who has owned EnginZyme over time?
EnginZyme has been through 4 private-equity ownership periods: Sofinnova Partners · via Sofinnova Industrial Biotech · since 2019; Industrifonden · via Industrifonden Evergreen · since 2021; Almi Invest · via Almi Invest (Regional funds) · since 2022; Navigare Ventures · via Navigare Ventures · since 2022.
Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue